| scholarly article | Q13442814 |
| P2093 | author name string | C A Barnes | |
| A Davoren | |||
| P McParland | |||
| W G Murphy | |||
| P2860 | cites work | 348 cases of suspected neonatal alloimmune thrombocytopenia | Q28256185 |
| The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening | Q28283146 | ||
| Evaluation of an enzyme-linked immunosorbent assay kit (GTI PakPlus) for the detection of antibodies against human platelet antigens | Q33328571 | ||
| Inadequacies in the postnatal management of fetomaternal alloimmune thrombocytopenia (FMAIT). | Q33328712 | ||
| A rapid one-stage whole-blood HPA-1a phenotyping assay using a recombinant monoclonal IgG1 anti-HPA-1a | Q33331591 | ||
| Neonatal alloimmune thrombocytopenia | Q33333226 | ||
| Provision of platelet support for fetuses and neonates affected by severe fetomaternal alloimmune thrombocytopenia | Q33337102 | ||
| A less invasive treatment strategy to prevent intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia | Q33339043 | ||
| Antenatal management of alloimmune thrombocytopenia with intravenous γ-globulin: A randomized trial of the addition of low-dose steroid to intravenous γ-globulin | Q33438829 | ||
| Neonatal alloimmune thrombocytopenia: detection and characterization of the responsible antibodies by the platelet immunofluorescence test. | Q33483557 | ||
| Human platelet antigen-1 (Zw) typing of fetuses by analysis of polymerase chain reaction-amplified genomic DNA from amniocytes | Q33487895 | ||
| Antenatal screening for fetal alloimmune thrombocytopenia: the results of a pilot study | Q33489976 | ||
| Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis | Q33490427 | ||
| Fetal thrombocytopenia and its relation to maternal thrombocytopenia | Q33494198 | ||
| A whole blood assay for platelet HPA1 (PLA1) phenotyping applicable to large-scale screening. | Q33495213 | ||
| Alloimmune thrombocytopenia of the newborn: neurodevelopmental sequelae | Q33496391 | ||
| Devastating sequelae of alloimmune thrombocytopenia: an entity that deserves more attention | Q33496829 | ||
| Therapy with intravenous immunoglobulin G (ivIgG) during pregnancy for fetal alloimmune (HPA-1a(Zwa)) thrombocytopenic purpura | Q33496889 | ||
| HPA genotyping by PCR sequence-specific priming (PCR-SSP): a streamlined method for rapid routine investigations | Q33498869 | ||
| Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group | Q33499546 | ||
| Feto-maternal alloimmune thrombocytopenia: antenatal therapy with IvIgG and steroids--more questions than answers. European Working Group on FMAIT. | Q33501515 | ||
| Human platelet-specific alloantigens: update | Q33503320 | ||
| Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies | Q34039655 | ||
| Complications of fetal blood sampling | Q40909687 | ||
| Time costs of caring for children with severe disabilities compared with caring for children without disabilities | Q50310822 | ||
| Neonatal alloimmune thrombocytopenia | Q68039963 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombocytopenia | Q585285 |
| P304 | page(s) | 289-292 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Journal of Clinical Pathology | Q6294965 |
| P1476 | title | Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases | |
| P478 | volume | 55 |
| Q33347954 | Antenatal screening for human platelet antigen‐1a: results of a prospective study at a large maternity hospital in Ireland |
| Q92887664 | Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia |
| Q95545418 | Fetal and neonatal alloimmune thrombocytopenia |
| Q92477144 | Fetal and neonatal alloimmune thrombocytopenia - The Norwegian management model |
| Q33373042 | Fetoneonatal alloimmune thrombocytopenia (FNAIT): our experience |
| Q92525071 | Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome |
| Q33360919 | HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: incidence and clinical outcome in 31 cases |
| Q33357123 | HPA-5b neonatal allo-immune thrombocytopenia: two cases described in Tunisia |
| Q33440153 | Human platelet antigen antibody induction in uncomplicated pregnancy is associated with HLA sensitization. |
| Q54537929 | Human platelet-specific antigens frequencies in the Argentinean population. |
| Q33416943 | Identification of anti-HPA-1a allo-antibodies using IgG platelet antibody detection and crossmatch system assay with Galileo Echo |
| Q33394444 | Mass-scale high-throughput multiplex polymerase chain reaction for human platelet antigen single-nucleotide polymorphisms screening of apheresis platelet donors |
| Q24673677 | Neonatal thrombocytopenia: causes and management |
| Q33440427 | Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia |
| Q33369697 | Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a |
| Q33403261 | Review of neonatal alloimmune thrombocytopenia |
| Q33393536 | The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources |
Search more.